Young Joseph R — SEC Form 4 filings
SEC reporting owner CIK 1861684. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-18 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 54,668 shares, $2,099,734 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 18,151 shares @ $42.22 ($766,317) in Vera Therapeutics, Inc., filed 2024-05-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | SVP, FINANCE, CHIEF ACCT OFFCR | 9 | — | 7 legs · 54,668 sh · $2,099,734 | 17 |
Form 4 filings — Young Joseph R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 5,000 @ $3.94 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 10,000 @ $3.94 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 3,117 @ $41.98 | EDGAR |
| 2026-02-06 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 15,000 @ $29.06 · Option exercise (M): 10,000 @ $3.94 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 10,740 @ $0 · Grant/award (A): 21,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Vera Therapeutics, Inc. (VERA) | Option exercise (M): 8,221 @ $3.94 · Sale (S): 8,221 @ $42.17 · Sale (S): 1,965 @ $42.68 · Option exercise (M): 18,151 @ $7.87 · Sale (S): 18,151 @ $42.22 · Option exercise (M): 2,500 @ $7.87 · +3 more | EDGAR |
| 2024-04-12 | 4 | Vera Therapeutics, Inc. (VERA) | Sale (S): 5,714 @ $40 | EDGAR |
| 2024-01-18 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 21,875 @ $0 · Grant/award (A): 81,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861684 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →